Literature DB >> 33464578

Functional outcome and quality of life after meningioma surgery: a systematic review.

Marco V Corniola1, Torstein R Meling1.   

Abstract

Assessment of long-term functional outcomes after meningioma surgery is important. We systematically reviewed the literature on health-related quality of life (HrQoL) and functional disability (FD) of patients after surgery for intracranial meningiomas. Using PRISMA 2015 guidelines, we screened 289 abstracts and 43 titles were retained for full-paper screening. 15 articles did not present enough data to meet the inclusion criteria and 7 articles failed to assess functional assessment and HrQoL. Twenty-two articles were included in our review. HrQol was assessed in N = 18 publications, most frequently using SF-36 (N = 10), followed by EQ5D-5L (N = 4), EORTC-QLQ (N = 4), and the FACT questionnaire (N = 2). The assessment of FD was reported in N = 11 publications, mostly using the KPS (N = 8). The Barthel index was used in N = 2 publications. Follow-up was reported in N = 12 publications, ranging from 6 months to 9 years. Scientific publications assessing long-term postoperative HrQol and FD in patients undergoing meningioma surgery are scarce and the data are heterogeneously reported, using various scales and follow-up protocols. Efforts should be undertaken to uniformly assess long-term post-operative functional outcomes in meningioma patients.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  extent of resection; meningioma; neurosurgery; outcome; quality of life; surgery; systematic review

Mesh:

Year:  2021        PMID: 33464578     DOI: 10.1111/ane.13395

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set.

Authors:  Silvia Schiavolin; Arianna Mariniello; Morgan Broggi; Giorgia Abete-Fornara; Alessandra Bollani; Giulio Palmas G; Gabriella Bottini; Matteo Querzola; Pina Scarpa; Alessandra Casarotti; Sara De Michele; Valeria Isella; Ilaria Mauri; Alessandra Maietti; Valentina Miramonti; Maria Immacolata Orru; Marta Pertichetti; Elisa Pini; Rossana Regazzoni; Sara Subacchi; Paolo Ferroli; Matilde Leonardi
Journal:  Neurol Sci       Date:  2022-06-02       Impact factor: 3.830

2.  Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

Authors:  Matthias Preusser; Antonio Silvani; Emilie Le Rhun; Riccardo Soffietti; Giuseppe Lombardi; Juan Manuel Sepulveda; Petter Brandal; Lucy Brazil; Alice Bonneville-Levard; Veronique Lorgis; Elodie Vauleon; Jacoline Bromberg; Sara Erridge; Alison Cameron; Florence Lefranc; Paul M Clement; Sarah Dumont; Marc Sanson; Charlotte Bronnimann; Carmen Balaná; Niklas Thon; Joanne Lewis; Maximilian J Mair; Philipp Sievers; Julia Furtner; Josef Pichler; Jordi Bruna; Francois Ducray; Jaap C Reijneveld; Christian Mawrin; Martin Bendszus; Christine Marosi; Vassilis Golfinopoulos; Corneel Coens; Thierry Gorlia; Michael Weller; Felix Sahm; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

3.  Long-term neurocognitive, psychological, and return to work outcomes in meningioma patients.

Authors:  Angela Sekely; Konstantine K Zakzanis; Donald Mabbott; Derek S Tsang; Paul Kongkham; Gelareh Zadeh; Kim Edelstein
Journal:  Support Care Cancer       Date:  2022-01-18       Impact factor: 3.359

4.  Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section.

Authors:  Marco V Corniola; Pierre-Hugues Roche; Michaël Bruneau; Luigi M Cavallo; Roy T Daniel; Mahmoud Messerer; Sebastien Froelich; Paul A Gardner; Fred Gentili; Takeshi Kawase; Dimitrios Paraskevopoulos; Jean Régis; Henry W S Schroeder; Theodore H Schwartz; Marc Sindou; Jan F Cornelius; Marcos Tatagiba; Torstein R Meling
Journal:  Brain Spine       Date:  2022-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.